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ABSTRACT 
High birth weight is an established risk factor for childhood acute lymphoblastic 
leukemia (ALL), especially in children younger than 5 years of age at diagnosis. The 
goal of this study was to explore the association between being born large for 
gestational age and the risk for ALL by race/ethnicity to determine if the role of this risk 
factor differed by these characteristics. The authors compared birth certificate data of 
575 children diagnosed with ALL who were younger than 5 years and included in the 
Texas Cancer Registry, Texas Department of Health, between the years 1995 and 2003 
with 11,379 controls matched by birth year. Stratified odds ratios were calculated for risk 
of ALL by birth weight for gestational age, categorized in 3 groups, small, appropriate, 
and large for gestational age (SGA, AGA, LGA, respectively), for each race/ethnicity 
group. The risk of developing ALL was higher among Hispanics who were LGA (odds 
ratio [OR]= 1.90, 95% confidence interval [CI]: 1.34-2.68) compared with LGA non-
Hispanic whites (OR= 1.27, 95% CI: 0.87-1.86) after adjusting for infant gender, year of 
birth, maternal age, birth order, and presence of Down syndrome. However, the 
difference was not statistically significant. These results suggest that there may be 
differences in the association between higher growth in utero and risk of childhood ALL 
among Hispanics versus non-Hispanic whites.  
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INTRODUCTION 
Acute lymphoblastic leukemia (ALL), the most common pediatric malignancy, 
represents about 25% of childhood cancers among those younger than 20 years of age, 
with approximately 4900 new cases diagnosed annually in the United States.1 
Approximately 5% of cases are attributable to a genetic condition,2 exposure to 
radiation,3,4 or previous chemotherapy treatment.5 However, most cases are of unknown 
etiology. In spite of this, some risk factors have been consistently associated with ALL. 
For instance, males have a higher incidence of ALL compared to females, and 
Hispanics (i.e., those from Spanish-speaking countries, especially those of Latin 
America) have a higher incidence compared with other racial/ethnic categories.6,7 
Additionally, high birth weight (HBW) is an established risk factor for the development of 
ALL.8,9  
The mechanism underlying the association between HBW and ALL remains 
unclear; therefore, it is important to better characterize this relationship. For instance, 
birth weight corrected for gestational age (BWGA) is a better measure for ALL risk than 
HBW alone.10-13 Specifically, in our own assessment using a large population-based 
sample from Texas, we demonstrated that large for gestational age (LGA) categories 
yielded more precise estimates of the association between birth weight and ALL 
compared to birth weight categories.10 Although there are differences in risk of ALL 
between Hispanics and non-Hispanic whites there are also differences between these 
groups on mean birth weight and preterm birth rate.14,15 In spite of this, ethnic 
differences have not been fully explored in the context the association between LGA 
and ALL risk. 
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As the incidence of ALL is higher among Hispanics compared with non-Hispanic 
whites, there is a need to better distinguish risk factors among this population. 
Therefore, the objective of this study was to evaluate the association between birth 
weight corrected for gestational age BWGA and ALL among Hispanics and compare 
those findings with those among non-Hispanic whites. This population-based case-
control study from the Texas Cancer Registry identified 575 childhood ALL cases and 
11,379 controls is one of the largest of its kind. 
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MATERIALS AND METHODS 
Selection of Cases and Controls 
This study was approved by the Texas Cancer Registry (TCR) institutional review 
board (IRB) for use of its data; the Texas Department of State Health Services (DSHS) 
IRB for use of birth records from the Bureau of Vital Statistics; and the Baylor College of 
Medicine IRB. Details of study design and methods have been described elsewhere.10 
In brief, birth certificate data were collected from all children who were singleton births in 
Texas, aged less than five years, diagnosed with a malignancy between 1995 and 
2003, and registered by the TCR of the DSHS (N=3450). TCR data were linked to birth 
certificate data using a probabilistic linkage software program AUTOMATCH 
Generalized Record Linkage System software (Match Ware Technologies, Silver 
Spring, MD, 1992); and 2673 of the initially identified 3450 total cases (77%) were 
successfully matched to their birth records. The control subjects were drawn from 
residual (i.e., not matched to TCR) Texas birth files for the study period and frequency-
matched at a 5:1 ratio to all cancer cases on birth year only. Cases and controls were 
excluded if gestational age (GA) and/or BW were missing or if BW was less than 500 g. 
Specifically, 11.6% of cases versus 12.4% of controls were missing information on GA 
and/or BW. After these exclusions, there were a total of 575 ALL cases and 11,379 
control subjects available for analysis. 
Data abstraction 
Details of data abstraction have been described elsewhere.10 Briefly, we 
extracted data from the birth certificate files for variables previously associated with 
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childhood cancer or plausibly associated with BW, GA, or childhood cancer. The 
variables abstracted and used in the analyses included: infant gender, race/ethnicity 
(recorded as the race of the mother on the birth certificate in The State of Texas), birth 
order, maternal age, paternal age, GA (in weeks), BW (in grams), and having a 
congenital malformation or Down syndrome. BW and GA were used to calculate BWGA. 
Specifically, race- and gender-specific growth curve data16 were used to categorize 
each subject’s weight corrected-for-gestational age as small for GA (SGA), appropriate 
for GA (AGA), or LGA. The LGA category included children whose weight at the given 
GA was greater than the 90th percentile; the SGA category included children whose 
weight at each GA in weeks was below the 10th percentile.  
Statistical analysis 
Counts and proportions were used to evaluate differences between ALL cases 
and controls on the variables included in the analysis. We conducted unconditional 
logistic regression analysis to calculate odds ratios (ORs) and 95% confidence intervals 
(CIs) to determine the crude association between selected characteristics and ALL, 
stratified by race/ethnicity. In order to evaluate the adjusted association between BWGA 
and ALL, we used multivariable logistic regression, evaluating the following factors as 
potential confounders: infant gender (male or female), maternal age (<20, 20-24, 25-29, 
30-34, ≥35), paternal age (<20, 20-24, 25-29, 30-34, ≥35), birth order (1, 2, ≥3), 
congenital malformation (yes or no), and Down syndrome (yes or no).10,17 As cases and 
controls were frequency-matched on year of birth, all models were adjusted for this 
variable. In addition based on previous studies, we opted to include infant gender, birth 
order, maternal age, and presence of Down syndrome in all models.10 Finally, in order 
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to determine if there were differences between non-Hispanic whites and Hispanics for 
the risk of ALL by BWGA, we conducted the Breslow-Day test of homogeneity. All 
statistical tests were 2-sided and performed with Stata software, version 13 (College 
Station, TX). We considered a 2-sided P value of <.05 as statistically significant.  
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RESULTS 
Complete epidemiologic data were available on 575 ALL cases and 11,379 
controls subjects. Birth characteristics are summarized in Table 1. Cases were more 
likely to be Hispanic or non-Hispanic white compared with controls (48.4% vs. 45.9% 
and 47.1% vs. 42.3%, respectively). Compared to controls, cases were more likely to be 
male (55.8% vs. 50.8%), born to mothers ≥30 years of age (31.7% vs. 28.2%), born to 
fathers ≥30 years of age (43.1% vs. 36.7%), LGA (14.1% vs. 9.8%), have a BW ≥4000 
grams (15.0% vs. 10.4%), born with a congenital malformation (1.4% vs. 0.8%), and 
have Down syndrome (0.7% vs. 0.04%). 
Unadjusted associations between selected variables and ALL by race/ethnicity 
are presented in Table 2. Among non-Hispanic whites, there were significant 
associations between ALL and the following: maternal age (odds ratio [OR](25-29)= 1.88, 
95% confidence interval [CI]: 1.11-3.19; OR(30-34)= 1.98, 95% CI: 1.16-3.39; OR(≥35)= 
1.89, 95% CI: 1.05-3.40), having been born with congenital malformation (OR= 2.60, 
95% CI: 1.09-6.17), and having Down syndrome (OR= 17.99, 95% CI: 4.48-72.34). We 
also observed significant associations between ALL and being LGA (OR= 1.73, 95% CI: 
1.23-2.43), and having birth weight ≥4000 grams (OR= 1.70, 95% CI: 1.19-2.42) among 
Hispanics. None of the variables evaluated were significantly associated with ALL 
among non-Hispanic blacks. 
The risk of developing ALL was higher among Hispanics who were LGA (OR= 
1.90, 95% CI: 1.34-2.68) compared with LGA non-Hispanic whites (OR= 1.27, 95% CI: 
0.87-1.86) after adjusting for infant gender, year of birth, maternal age, birth order, and 
presence of Down syndrome (Table 3). Although LGA-associated ALL risk was higher in 
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Hispanics compared with non-Hispanic whites, the Breslow-Day test of homogeneity 
was P = .22.  
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DISCUSSION 
In one of the largest assessments of its kind, we assessed the differences 
between Hispanics and non-Hispanic whites on association between BWGA and ALL. 
Although the risk of ALL due to being LGA was about 50% higher among Hispanics 
when compared with non-Hispanic whites, the difference was not statistically significant.  
Other assessments have noted differences in the risk of ALL between Hispanics 
and non-Hispanic whites.18,19 In a Spanish population with ALL, García-Sanz et al.- 
observed an absence of TEL- AML1 gene translocation and suggested the presence of 
racial variation in terms of underlying etiology.19 This hypothesis was confirmed by 
another study in the United States population comparing Hispanics and non-Hispanic 
whites in California. Briefly, the percentage of TEL-AML1 gene translocation was 
significantly lower in Hispanics compared with non-Hispanic whites (P = .01).18 In 
addition, in one case-control study, Xu et al.20 evaluated the frequency of 49 ARID5B 
single-nucleotide polymorphisms and observed that the frequency of the ALL risk alleles 
(allele C) was higher in Hispanics compared with non-Hispanic whites. The authors 
concluded that ARID5B polymorphisms may contribute to racial disparities in the 
incidence of childhood ALL. Furthermore, Kennedy et al. reported differences in genetic 
associations with the risk of childhood ALL between Hispanics and non-Hispanics 
whites.21,22 Therefore, previous assessments suggest the risk factor profile may differ 
between Hispanics and other groups. 
Although HBW is a well-established risk factor for development of childhood 
ALL,8,9 the biological mechanism underlying this association remains unclear. 
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Furthermore, differential effects of HBW across race and ethnicity groups have not been 
extensively evaluated. The association of BW and the risk of childhood cancer by 
race/ethnicity was previously studied by Okcu et al.23 Unlike the present study, the 
authors studied BW alone instead of BWGA, which we believe is a better predictor for 
occurrence of ALL in children.10 They showed that the variable of race/ethnicity did not 
influence the association between BW and childhood ALL.23 Unlike the previous study, 
the association between LGA and ALL was about 50% stronger among Hispanics when 
compared with non-Hispanic whites.   
Our findings must be considered in the light of certain limitations. For instance, 
using GA to define risk group limited the number of potential cases and controls 
available for analysis. Additionally, some subjects were missing information on GA 
and/or BW. However, proportions were similar between cases and controls, which limits 
the possibility of selection bias. The data for the GA may not be recorded properly in 
birth certificates, which can lead to exposure misclassification bias by incorrectly 
categorizing subjects with respect to their BWGA. As this is not likely to vary by case 
status, we believe the potential for misclassification would be nondifferential, leading to 
our effect estimates being biased towards the null.24 Additionally, use of maternal self-
reported race and ethnicity may introduce some heterogeneity. Third, the study 
population is limited to those who were born and diagnosed in Texas, therefore, children 
who moved out of the state prior to diagnosis or children not born in Texas could not be 
included in this assessment. A final limitation of this study is that 23% of the cases were 
not linked to birth records. This is likely due to cases diagnosed in Texas who were not 
born in the state. It should also be noted that some children born in Texas might be 
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diagnosed with cancer in other states and not ascertained by the Texas Cancer 
Registry. Although it is difficult to determine the direction in which this may bias our 
results, we believe movement between cases and controls is likely nondifferential.25 
Therefore, we believe our effect estimates would be biased toward the null based on 
this limitation.24 
Strengths of this study include a large sample size. In addition, we used a growth 
curve data provided by Alexander16 to assess neonatal growth and BWGA, which we 
previously showed is a better measurement in defining standardized risk groups than 
BW alone.10 Finally, we utilized data from a large population-based cancer registry that 
enabled us to evaluate the role of BWGA on ALL risk among Hispanics. 
In summary, despite some important limitations, we found a somewhat stronger 
association between high BWGA and ALL among Hispanics compared with non-
Hispanic whites. This information supports the etiologic underpinnings of ALL may be 
different in Hispanics compared with other groups. We recommend that future research 
would benefit from defining Hispanic ethnicity based on genomic ancestry. Additionally, 
characterizing the biological mechanism underlying the association between BWGA and 
childhood ALL may be informative for future prevention strategies.   
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Table 1. Characteristics of ALL cases and controls in Texas, 1995-2003 
Variable ALL cases 
(N=575) 
Controls  
(N=11,379) 
Gender, n (%)         
     Female  254  (44.2)  5,598  (49.2)  
     Male  321  (55.8)  5,781  (50.8)  
Race/ethnicity,a n (%)         
     Non-Hispanic white  271  (47.1)  4,808  (42.3)  
     Non-Hispanic black  26  (4.5)  1,346  (11.8)  
     Hispanic  278  (48.4)  5,225  (45.9)  
Maternal Age (years), n (%)         
     Mean (SD) 26.6  (6.0)  25.9  (6.0)  
     <20 69  (12.0)  1,823  (16.0)  
     20-24 153  (26.6)  3,286  (28.9)  
     25-29 171  (29.7)     3,071  (27.0)  
     30-34 124  (21.6)  2,147  (18.9)  
     ≥35 58  (10.1)  1,052  (9.3)  
Paternal Age (years), n (%)         
     Mean (SD) 29.8  (6.9)  28.9  (6.8)  
     <20 26  (4.5)  528  (5.1)  
     20-24 95  (16.5)  2,170  (19.1)  
     25-29 135  (23.5)     2,721  (23.9)  
     30-34 123  (21.4)  2,301  (20.2)  
     ≥35 125  (21.7)  1,872  (16.5)  
     Missing 71  (12.4)  1,733  (15.2)  
Gestational age (weeks)         
     < 37  56  (9.7)  1,104  (9.7)  
     37-40 459  (79.8)  8,982  (78.9)  
     ≥41 60  (10.4)  1,293  (11.4)  
Weight corrected for 
gestational age 
        
     SGA 48  (8.3)  1,219  (10.7)  
     AGA 446  (77.6)  9,040  (79.4)  
     LGA 81  (14.1)  1,120  (9.8)  
Birth weight (g)         
     ≤2,500 26  (4.5)  642  (5.6)  
     2,501-3,999 463  (80.5)  9,557  (84.0)  
     ≥4,000 86  (15.0)  1,180  (10.4)  
Birth Order         
     1 235  (42.65)  4,520  (41.16)  
     2 166  (30.13)  3,355  (30.55)  
     ≥3 150  (27.22)  3,106  (28.29)  
Congenital malformation         
     No  555  (96.5)  11,136  (97.9)  
     Yes       8  (1.4)  92  (0.8)  
     Missing 12  (2.1)  151  (1.3)  
Down syndrome         
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      No     571  (99.3)  11,374  (99.96)  
     Yes 4  (0.7)  5  (0.04)  
Note. SD= standard deviation 
a
Recorded on birth certificates as the race of the mother for controls;. 
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Table 2. Associations between birth characteristics and ALL by race/ethnicity in Texas, 1995-2003 
   Non-Hispanic  Whites 
       Cases/controls 
         (271/4,808) 
Non-Hispanic  Blacks 
     Cases/controls 
         (26/1,346) 
Hispanics 
Cases/controls 
(278/5,225) 
Variable OR  95% CI  OR  95% CI  OR  95% CI 
Gender           
     Female  1.00  (Ref.)  1.00  (Ref.)  1.00 (Ref.) 
     Male  1.21  (0.94-1.54)  1.72  (0.76-3.89)  1.22 (0.96-1.55) 
Maternal Age (years)           
     <20  1.00  (Ref.)  1.00  (Ref.)  1.00 (Ref.) 
     20-24 1.49  (0.86-2.58)  0.75  (0.24-2.34)  1.14 (0.79-1.65) 
     25-29 1.88  (1.11-3.19)    1.32  (0.44-3.98)  1.20 (0.83-1.74) 
     30-34 1.98  (1.16-3.39)  1.16  (0.35-3.84)  1.24 (0.81-1.88) 
     ≥35 1.89  (1.05-3.40)  1.01  (0.20-5.08)  1.17 (0.68-2.00) 
Paternal Age (years)           
     <20  1.00  (Ref.)    1.00  (Ref.)  1.00 (Ref.) 
     20-24 0.78  (0.35-1.72)  0.60  (0.11-3.34)    1.15 (0.65-2.02) 
     25-29 1.03  (0.49-2.19)    0.31  (0.04-2.24)  1.18 (0.67-2.06) 
     30-34 1.15  (0.54-2.43)  0.72  (0.13-4.00)  1.16 (0.65-2.06) 
     ≥35 1.38  (0.65-2.92)  1.00  (0.20-5.08)  1.56 (0.87-2.79) 
Gestational age (weeks)           
     < 37  1.23  (0.81-1.85)  0.22  (0.03-1.64)    1.03 (0.68-1.54) 
     37-40  1.00  (Ref.)     1.00  (Ref.)  1.00 (Ref.) 
     ≥41 0.76  (0.50-1.17)  0.62  (0.14-2.64)  1.08 (0.75-1.57) 
Weight corrected for 
gestational age 
          
     SGA 0.87  (0.56-1.34)  1.44  (0.49-4.28)  0.68 (0.43-1.08) 
     AGA  1.00  (Ref.)     1.00    (Ref.)  1.00 (Ref.) 
     LGA 1.27  (0.88-1.84)  0.82  (0.19-3.55)  1.73 (1.23-2.43) 
Birth weight (g)           
     ≤2,500 0.53  (0.25-1.15)  1.53  (0.52-4.55)  1.16 (0.68-1.99) 
     2,501-3,999  1.00  (Ref.)  1.00  (Ref.)  1.00 (Ref.) 
     ≥4,000 1.25  (0.90-1.74)  1.59  (0.36-6.93)  1.70 (1.19-2.42) 
Birth Order           
     1 1.00  (Ref.)  1.00    (Ref.)  1.00 (Ref.) 
     2 1.00  (0.76-1.33)  0.62  (0.23-1.64)  0.92 (0.67-1.26) 
     ≥3 0.91  (0.66-1.25)  0.70  (0.28-1.77)  1.00 (0.75-1.35) 
Congenital malformation           
     No  1.00   (Ref.)  1.00    (Ref.)  1.00 (Ref.) 
     Yes     2.60   (1.09-6.17)   N/Aa  N/A  1.08 (0.26-4.51) 
Down syndrome           
      No   1.00        (Ref.)       1.00       (Ref.)  1.00         (Ref.) 
     Yes 17.99  (4.48-72.34)  N/Aa       N/A    N/Aa N/A 
Note. SGA=Small for Gestational Age; AGA=Average for Gestational Age; LGA=Large for Gestational Age; 
aSome cells have zero observation. 
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Table 3. Risk of ALL by birth weight corrected for gestational age by ethnicity in Texas, 1995-2003 
Weight corrected for 
gestational age 
Adjusteda OR (95% CI) 
Non-Hispanic white 
Adjusteda OR (95% CI) 
Hispanic 
P for 
Heterogeneity 
SGA 0.90 (0.58-1.40) 0.76 (0.47-1.22) .22 
AGA 1.00 (Ref.) 1.00 (Ref.)  
LGA 1.27 (0.87-1.86) 1.90 (1.34-2.68)  
Note.SGA=Small for Gestational Age; AGA=Average for Gestational Age; LGA=Large for Gestational 
Age.aAdjusted for infant gender, and maternal age. 
 
 
 
 
 
  
17 
 
REFERENCES 
1. American Cancer Society. Stat bite: Estimated new leukemia cases in 2008. J Natl 
Cancer Inst. 2008;100(8):531. 
2. Wiemels J. Perspectives on the causes of childhood leukemia. Chem Biol Interact. 
2012;196(3):59-67. 
3. Wakeford R, Kendall G, Little M. The proportion of childhood leukaemia incidence in 
great britain that may be caused by natural background ionizing radiation. Leukemia. 
2009;23(4):770-776. 
4. Spector L, Ross J, Robinson L,  Bhatia S. Epidemiology and etiology. In: Pui CH, ed. 
Childhood leukemias. The United States of America: Cambridge University Press; 
2006:48-68. 
5. Scheurer M, Bondy M,  Gurney J. Epidemiology of childhood cancer. In: Pizzo P and 
Poplack D, eds. Principles and practice of pediatric oncology. Philadelphia, PA: 
Lippincott Williams & Wilkins; 2006:2-16. 
6. Linet MS and Devesa SS. Descriptive epidemiology of childhood leukaemia. Br J 
Cancer. 1991;63(3):424-429. 
7. McNeil DE, Cote TR, Clegg L, Mauer A. SEER update of incidence and trends in 
pediatric malignancies: acute lymphoblastic leukemia. Med Pediatr Oncol. 
2002;39(6):554-557. 
8. Caughey RW and Michels KB. Birth weight and childhood leukemia: a meta-analysis 
and review of the current evidence. Int J Cancer. 2009;124(11):2658-2670. 
9. O'Neill K, Bunch K, Murphy M. Intrauterine growth and childhood leukemia and 
lymphoma risk. Expert Rev Hematol. 2010;5(5):559-576. 
10. Sprehe MR, Barahmani N, Cao Y, et al. Comparison of birth weight corrected for 
gestational age and birth weight alone in prediction of development of childhood 
leukemia and central nervous system tumors. Pediatr Blood Cancer. 2010;54(2):242-
249. 
11. Milne E, Laurvick CL, Blair E, Bower C, de Klerk N. Fetal growth and acute 
childhood leukemia: looking beyond birth weight. Am J Epidemiol. 2007;166(2):151-159. 
12. Milne E, Greenop KR, Metayer C, Schüz J, Petridou E, et al. Fetal growth and 
childhood acute lymphoblastic leukemia: findings from the childhood leukemia 
international consortium. Int J Cancer. 2013;133(12):2968-2979. 
13. Roman E, Lightfoot T, Smith AG, Forman MR, Linet MS, et al. Childhood acute 
lymphoblastic leukaemia and birthweight: insights from a pooled analysis of case-
control data from Germany, the United Kingdom and the United States. Eur J Cancer. 
2013;49(6):1437-1447. 
18 
 
14. Buekens P, Notzon F, Kotelchuck M, Wilcox A. Why Do Mexican Americans Give 
Birth to Few Low-Birth-Weight Infants? Am J Epidemiol. 2000;152(4):347-351. 
15. Madan A, Holland S, Humbert JE, Benitz WE. Racial differences in birth weight of 
term infants in a northern California population. J Perinatol. 2002;22(3):230-235. 
16. Alexander G, Kogan M, Himes J. 1994-1996 U.S. singleton birth weight percentiles 
for gestational age by race, Hispanic origin, and gender. Matern Child Health J. 
1999;3(4):225-231. 
17. Oksuzyan S, Crespi CM, Cockburn M, Mezei G, Kheifets L. Birth weight and other 
perinatal characteristics and childhood leukemia in California. Cancer Epidemiol. 
2012;36(6):e359-e365. 
18. Aldrich M, Zhang L, Wiemels J, et al. Cytogenetics of Hispanic and White children 
with acute lymphoblastic leukemia in California. Cancer Epidemiol Biomarkers Prev. 
2006;15(3):578-581. 
19. García-Sanz R, Alaejos I, Orfão A, et al. Low frequency of the TEL/AML1 fusion 
gene in acute lymphoblastic leukaemia in Spain. Br J Haematol. 1999;107(3):667-669. 
20. Xu H, Cheng C, Devidas M, et al. ARID5B Genetic Polymorphisms Contribute to 
Racial Disparities in the Incidence and Treatment Outcome of Childhood Acute 
Lymphoblastic Leukemia. J Clin Oncol. 2012;30(7):751-757. 
21. Kennedy A, Kamdar K, Lupo P, Okcu M, Scheurer M, Dorak M. Genetic markers in 
a multi-ethnic sample for childhood acute lymphoblastic leukemia risk. Leuk Lymphoma. 
2014;16:1-16. 
22. Kennedy A, Kamdar K, Lupo P, et al. Examination of HFE associations with 
childhood leukemia risk and extension to other iron regulatory genes. Leuk Res. 
2014;38(9):1055-1060. 
23. Okcu M, Goodman K, Carozza S, et al. Birth weight, ethnicity, and occurrence of 
cancer in children: a population-based, incident case-control study in the State of 
Texas, USA. Cancer Causes Control. 2002;13(7):595-602. 
24. Rothman KJ. Biases in Study Design. In: Rothman KJ, ed. Epidemiology: An 
Introduction. New York, NY: Oxford University Press Inc.; 2002:94-112. 
25. Lupo PJ, Symanski E, Chan W, et al. Differences in exposure assignment between 
conception and delivery: the impact of maternal mobility. Paediatr Perinat Epidemiol. 
2010;24(2):200-208. 
 
